Fitbit has completed clinical trials of its own ECG feature and is looking to get FDA approval – as it launches a large scale study into Afib and irregular heart rate detection. The mass Fitbit Heart ...
HeartBeam’s synthesised 12-lead electrocardiogram (ECG) has met the clinical endpoints in the VALID-ECG pivotal study, assessing non-life-threatening arrhythmias. In the study, the mean difference in ...
Please provide your email address to receive an email when new articles are posted on . Abnormal ECG findings were rare in elite female basketball players. These data may serve as a reference for ...
Even minor ECG abnormalities detected with annual checks signal a greater risk of future CVD events, a study of several million working-age people affirms, although questions remain about whether ...
Cardiologists regularly get calls from people who are freaked out by the fitness tracker on their wrist. Typically, the caller is young and healthy, maybe even a half-marathoner, says Cleveland Clinic ...
Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More Peer-reviewed medical journal JAMA Cardiology today published a study ...
Shrinking waveforms on electrocardiograms may serve as an indicator of which hospitalized COVID-19 and flu patients are at risk of declining health or death, according to findings published Sept. 25 ...
Sept. 24 (UPI) --Changes in heart function observed on electrocardiograms of patients hospitalized with COVID-19 or influenza can help predict a time frame for worsening health, a study published ...
ECG abnormalities detected as part of a cardiac screening program mandated by the National Basketball Association (NBA) were found in 15.6% of active players and potential draftees, a new analysis ...
A study published in Nature Medicine reports the ability of a smartwatch ECG to accurately detect heart failure in nonclinical environments. Researchers at Mayo Clinic applied artificial intelligence ...
The electrocardiogram test commonly given to people suspected of having cramping chest pains from angina have limited value when it comes to predicting future heart problems, a new study suggests.